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Summary: Surgical resection with free surgical margins is the cornerstone of successful primary
treatment of vulvar squamous cell carcinoma (VSCC). In general reexcision is recommended
when the minimum peripheral surgical margin (MPSM) is<8mmmicroscopically. Pathologists
are, therefore, required to report the minimum distance from the tumor to the surgical margin.
Currently, there are no guidelines on how to make this measurement, as this is often considered
straightforward. However, during the 2018 Annual Meeting of the British Association of
Gynaecological Pathologists (BAGP), a discussion on this topic revealed a variety of opinions
with regard to reporting and method of measuring margin clearance in VSCC specimens.
Given the need for uniformity and the lack of guidance in the literature, we initiated an
online survey in order to deliver a consensus-based definition of peripheral surgical margins
in VSCC resections. The survey included questions and representative diagrams of peripheral
margin measurements. In total, 57 pathologists participated in this survey. On the basis of
consensus results, we propose to define MPSM in VSCC as the minimum distance from the
peripheral edge of the invasive tumor nests toward the inked peripheral surgical margin
reported in millimeters. This MPSM measurement should run through tissue and preferably
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be measured in a straight line. Along with MPSM, other relevant measurements such as
depth of invasion or tumor thickness and distance to deep margins should be reported. This
manuscript provides guidance to the practicing pathologist in measuring MPSM in VSCC
resection specimens, in order to promote uniformity in measuring and reporting. Key Words:
Surgical margin—Vulvar cancer—Measurement.
Vulvar squamous cell carcinoma (VSCC), the most
common vulvar malignancy (1), is notorious for its high
recurrence rates, with a reported local recurrence
frequency of up to 40% ten years after primary
treatment (2). In an effort to limit these recurrence
rates, most guidelines including The Royal College of
Obstetricians & Gynaecologists (RCOG) in the United
Kingdom, recommend surgical excision with a histo-
logical minimum tumor-free peripheral surgical margin
(MPSM) of > 8mm (3–6). Retrospective cohort studies
support this approach, showing 0% recurrence rates for
> 8mm margins and 47% when the margins are ≤ 8
mm (4,7,8), although recent studies have argued that
the 8mm threshold might be too stringent (9–12). The
concept of ontogenic cancer fields might explain why
the width of the tumor-free resection margin is not a
consistent predictor of local recurrence (13). However,
when surgical treatment of VSCC in respect to the
theory of cancer as inverse morphogenesis is carried
out, it is still important to measure the MPSM as a
pathologic quality. In order to achieve this requirement,
surgeons often need to sacrifice critical structures
adjacent to the VSCC (e.g. clitoris, urethra, and anus)
with subsequent morbidities (14). If the 8mmMPSM is
not reached, most guidelines recommend consideration
of reexcision and/or adjuvant radiotherapy to reduce
the chance of local recurrence (9). Therefore, MPSM
measurement is a mandatory and clinically important
item in pathology reporting and clinical care.
Despite its clinical relevance, practical guidelines on
how to measure the MPSM are lacking in the current
literature. This is in contrast to depth of stromal
invasion and/or tumor thickness, for which definitions
and guidance on measurement have been published
(15,16). During the British Association of Gynaecologic
Pathologists (BAGP) Annual Meeting in 2018, an
ad hoc pilot survey revealed considerable disagreement
among pathologists on how to measure MPSM. This
topic seems particularly relevant to vulvar resections, as
the vulva has natural folds that form the anatomical
landmarks such as the labia, and tumors are often
exophytic, resulting in scenarios in which the correct
measurement is not obvious. This is compounded by a
lack of agreement between the naked eye measurement
made at the time of surgery and that reported
histologically after formalin fixation (17). Surgical
assessment of margin clearance is based on measuring
skin adjacent to tumor when the skin has been pulled
taut/flat. Various factors may affect the histological
assessment, including variation in laboratory protocols
with regard to pinning specimens before fixation,
shrinkage as a result of fixation, and/or the presence
of microscopic tumor deep to the surface extending
closer to the margin than is apparent from assessment
of the skin surface. As patient care and future research
studies would clearly benefit from a uniform and
standardized approach toward measuring MPSM in
VSCC, we undertook an online survey among members
of the BAGP in order to formulate recommendations
for uniform MPSM measurement and reporting. These
recommendations are likely to not only be relevant for
VSCC, but also for other skin/mucosal resections for
which peripheral margin measurements are required.
METHODS
Four pathologists with a specialist interest in
gynecologic, including vulvar pathology (K.K.V.d.V.,
C.B.G., N.S., and T.B.), discussed the common
problems encountered in MPSM measurement of
VSCC following the 2018 BAGP meeting. This group
designed a survey including questions and challenging
scenarios for MPSM measurement. The questions were
sent to members of the BAGP council for comments.
A link to the final agreed electronic online survey was
sent to all members of the BAGP in November 2018.
The survey included 5 diagrams representing potential
problematic areas in MPSM measurement. In each
diagram, multiple options for measuring margin distance
were drawn, and the participants were asked to select their
preferred MPSM (only one answer allowed). The first
diagram represents a straightforward MPSM measure-
ment (Supplemental Fig. 1, Supplemental Digital Content
1, http://links.lww.com/IJGP/A99) and was included to
make participants familiar with the online webtool. Five
multiple-choice questions were also included in the survey
(Fig. 1). Participants were encouraged to submit
comments related to the topic, which have been
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incorporated in the discussion of this manuscript.
Responses received until the end of December 2018
were analyzed, excluding any that were incomplete.
RESULTS
A total of 57 BAGP members responded, and all
these participants fully completed the survey. Impor-
tantly, an overwhelming majority (96%) replied that
recommendations for measuring MPSM would be
useful in daily practice. This was reinforced by
responses to the question on whether they experienced
difficulties in measuring MPSM in daily practice, to
which 14% and 68% respondents, respectively, selected
“often” and “occasionally,” as opposed to 12% and 5%,
respectively, stating that they rarely or never experi-
enced difficulties when measuring MPSM (Fig. 1).
Problematic Area 1: Should the MPSM Always be
Measured Toward the Peripheral Surface Edge?
Because of the irregular vulvar surface a measurement
toward the peripheral inked epithelial-surface edge may
not always represent the shortest distance. As illustrated
in Figure 2A, the shortest measurement from the tumor
to the resection edge, in this scenario, is toward the inked
soft tissue edge. In keeping with measuring the shortest
distance, the majority of participants (86%) chose option
B, measuring from the peripheral edge of the invasive
tumor to the peripheral inked soft tissue edge.
Interestingly, a significant minority (14%) chose option
A, in which the distance is larger, but the measurement is
toward the epithelial-surface edge.
Comments
Most participants strictly applied the simple rule
that the MSPM is the shortest measurement toward
the peripheral inked edge even though this is a stromal
and not an epithelial margin. Some participants,
however, commented that it may be challenging to
decide where the peripheral margin stops and “the
deep surgical margin” begins. Another remark made
by one of the participants, was that measurement A is
more representative of what the surgeon measures
during the operation. Reporting measurement B (only)
could potentially result in a negative impact on
surgical audit, and therefore it was suggested (in these
scenarios) to report on both the MPSM (option B) and
also the “surface epithelial margin” (option A).
Provided both may be worthy of consideration, albeit
after good communication with local surgeons. As
long as it is clearly emphasized in the report that, for
decisions with regard to the patient’s adjuvant treat-
ment plan, measurement B is the most relevant.
Problematic Area 2: How Should MPSM be Measured
When the Epithelial Surface is Irregular/Curved?
Given the normal vulvar anatomy, an irregular or
curved surface is frequent in VSCC resection speci-
mens and may complicate the measurement of the
MSPM (Fig. 2B). Curved skin may be neutralized in
part by pulling the skin taut. However, artificial folds
due to processing can still appear and are difficult to
distinguish from natural irregularities. Depending on
how extreme this irregularity is, pathologists may
favor a curved line instead of a straight line. Curved
line measurements are impractical when using a
microscope, but, as the field moves toward digital
pathology, this practical problem becomes obsolete.
Interestingly, when faced with this scenario in our
survey, 98% of the participants considered that the
straight-line measurement is preferred.
Comments
The outcome of Figure 2B may have been influenced
by the fact that it is likely that few or none of the
participants have already moved toward digital
pathology in daily routine. The participants reported
that they used eyepiece reticles (50%), a ruler (either
stage vernier scale or the magnifying glass fixed with a
rule, 48%), or simply estimated the MPSM distance
(2%) in practice (Fig. 1). With the introduction of
digital pathology, more accurate margin measurements
can be anticipated. This increased accuracy introduces
another interesting question raised by one of the
participants; how accurately do we need to measure?
Most pathologists currently record measurements
rounded to the nearest whole millimeter; however,
digital pathology will allow for measurements of
hundredths of millimeters or less. There is currently
no evidence that this level of accuracy is required, and
therefore we would recommend that rounded
millimeters should remain the standard. Digital
pathology will also simplify measuring curved lines;
however, unless a curved measurement clearly
represents the true shortest distance toward the
periphery, for example, when a length of uninvolved
skin is embedded curved/folded in order to fit into a
paraffin block, this should be avoided. In addition, a
pitfall is not to overstretch the skin, because this might
lead to overestimation of the MPSM. It is unknown
whether measuring in a straight line compared with
measuring in a curved line will influence clinical
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FIG. 1. Five multiple choice questions were asked to all participating pathologists on how to measure and report on minimal peripheral
surgical margin.
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outcome. Uniform use of the recommendations from
this manuscript will help resolve this in the near future.
Problematic Area 3: How to Measure MPSM When
an Exophytic Tumor Protrudes Above the Adjacent
Surface Epithelium?
Often VSCC have an exophytic component, which
protrudes above the adjacent surface epithelium
(Fig. 3A). In these cases, the shortest distance from
the tumor to the periphery can be measured by drawing
a line outside the tissue (option A). The participants in
the survey agreed in an overwhelming majority (98%)
that, in this scenario, option A does not represent the
MPSM. We can deduce from this answer that the
MPSM measurement should not be outside the tissue.
This is informative, as this provides a useful “rule” for
measuring MPSM in cases with surface irregularities.
Problematic Area 4: Should MPSM Always be
Measured as a Straight Uninterrupted Line?
Figure 3B represents a case of an exophytic tumor
wherein the deepest point of invasion is above a collarette
FIG. 2. These diagrams represent a problematic area in measuring minimal peripheral surgical margin (MPSM) in vulvar cancer. In each
diagram, multiple options were drawn, and participants selected their preferred MPSM via an online survey. The results of this survey are
shown in the corresponding bar graph. The first question was: Should the minimal peripheral surgical margin always be measured towards the
peripheral surfage edge? The diagram and answer to this question are depicted in (A). The next question was: how to measure minimal
peripheral surgical margin when the epithelial surface is irregular/curved (B)?
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of uninvolved skin. In this case, two ways to measure the
MPSM by a straight uninterrupted line were presented
(option A and option D) and two ways in which the line
was interrupted at the collarette (option B and C). The
shortest distance is measurement A; however, following
the rule for not measuring outside the tissue (described
above, Fig. 3A), this would be incorrect. The alternative
straight uninterrupted line (option D) is the largest
distance of all options and was not the preferred option
by the participants (2%). The majority voted for option C
(95%), which represents the shortest distance through
tissue in a line with an angle at the collarette. From this,
we can conclude that the participants are familiar with this
scenario and allow for MPSM with an angle.
Additional Questions
In addition to the questions relating to the illustrated
scenarios, a few additional questions were asked, as below.
Should the Presence of a Precursor Lesion at the
Lateral Epithelial MPSM be Reported?
VSCC has 2 well-defined precancerous lesions that are
frequently recognized in the epithelial surface adjacent to
FIG. 3. These diagrams represent a problematic area in measuring minimal peripheral surgical margin (MPSM) in vulvar cancer. In each diagram,
multiple options were drawn, and participants selected their preferred MPSM via an online survey. The results of this survey are shown in the
corresponding bar graph. (A) Refers to the question: How to measure the minimal peripheral surgical margin when an exophytic tumor is overarching the
adjacent surface epithelium? (B) Answers the question: Should the minimal peripheral surgical margin always be measured as a straight uninterrupted line?
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the tumor, high-grade squamous intraepithelial lesion of
usual type (usual high-grade vulvar intraepithelial neo-
plasia) and differentiated vulval intraepithelial neoplasia.
It is possible that recurrent disease is not only determined
by the margin status of the invasive tumor, but also by the
presence and distance of the precancerous lesion to the
surgical margin. Here, the measurement itself is more
straightforward, as the precancer will always be measured
along the epithelial surface. Interestingly, with the
exception of the RCOG and College of American
Pathologists (CAP) guideline (3,18), most guidelines do
not consider reporting precancerous lesions in VSCC
resection specimens mandatory. Despite this, most of the
survey participants report upon the presence or absence of
precancerous lesions (98%) adjacent to the VSCC at the
peripheral margin. An overall 42% of these participants
also include a measurement of the in situ lesion to the
peripheral margin. The remaining 56% do not include a
measurement and limit the comment on the in situ lesion
to its presence/absence at the surgical margin (Fig. 1).
Should a Measurement of the Deep Soft Tissue Margin
also be Included in the Report?
Most participants (95%) also report on deep soft
tissue margins, in addition to the MPSM in their
VSCC resection specimens (Fig. 1). This is in line with
most guidelines (7), in which a minimum of three
measurements are listed: (1) tumor thickness/depth of
invasion, (2) the MPSM, and (3) the deep soft tissue
margin (3). One participant remarked to not limit the
measurement to the minimal margin, but report a
clockwise margin status. Measurement of distance to
multiple cutaneous margins has limited relevance; the
margins are approximated and stitched together
at the end of surgery (unless a skin flap has been
used to fill the gap), and therefore it is the involvement
of/proximity to the closest margin that is required
by clinicians to plan further management. Histology
reports should not be crowded with irrelevant
measurements. In many practices, clockwise meas-
urements are the standard during grossing, but these
measurements should not be included in the report to
avoid potential confusion.
SUMMARY
This is the first study to survey current practice in
measuring the MPSM in VSCC specimens. By
presenting 5 margin scenarios to 57 trained patholo-
gists with an interest in gynecologic pathology, we can
propose some broad rules that will help the community
arrive at more reproducible and accurate MPSM
measurements and uniform reporting. On the basis of
this, we propose the following:
 The MPSM is defined as: “the minimum distance
from invasive carcinoma to the inked peripheral
surgical margin reported in millimeters.”
 The peripheral margin is roughly perpendicular to
the skin surface; this includes the epithelial surface
and deeper soft tissue; the MPSM should, therefore,
be measured toward the peripheral stromal edge or
surface-epithelial edge, whichever is the shortest.
 Reporting both the MPSM and the distance to the
surface-epithelial edge is not mandatory for in-
vasive tumor, but may be considered for the
purpose of surgical audit. In addition, reporting
on both margins is recommended for high-grade
squamous intraepithelial lesion and differentiated
vulval intraepithelial neoplasia.
 The MPSM should be measured through tissue and
preferably in a straight uninterrupted line; however,
in some situations (collarette) a composite measure-
ment including separate linear measurements
joined at an angle may be required.
 Measuring the MPSM by a curved line in the
context of an irregular surface, which is now
possible due to the increased use of digital
pathology, is not recommended, unless this is felt
to represent a truer measurement, for example,
when a length of uninvolved skin is embedded
curved/folded in order to fit into a paraffin block.
 The presence or absence of precancerous lesions at
the surgical margin should be included in the report.
 Although there is no clear evidence to support the
value of recording the distance of precancerous
lesions from the nearest epithelial margin, it is
recommended that, for uniformity, in current
practice, this measurement should be included in
the report; this measurement is made along the
epithelial surface.
 The minimal deep surgical margin is generally
understood to be measured from the deepest
infiltrating tumor nest to the inked dorsal soft
tissue margin.
It is hoped that these recommendations will help to
uniform current clinical practice and can be used as a
reference for future guidelines and clinical studies to
correlate MPSM with patient outcome.
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